| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.00016 | 1 |